Health System

FDA approves extended-release formulation of ropinirole for Parkinson's disease.

Ethex has voluntarily recalled additional lots of morphine tablets since they may be oversized.

OIG has released a report on FDA's generic drug review process.

Humana members in areas affected by flooding or fires can get their refills filled earlier than usual.

The Centers for Medicare & Medicaid Services will speed up its processing of low-income subsidy eligibility claims processing.

Safewy has launched a $4 generic prescription drug discount program in eastern U.S. and Chicago areas.

Medical Services Co. has agreed to sell its workers' comp business to Express Scripts.

Pharmacy directors can consult a new white paper to learn how to prepare for a Joint Commission survey on environment of care.

NCPA issued a statement regarding the Medicare Improvements for Patients and Providers Act of 2008.

An investigation by Attorney General Andrew Cuomo has found expired products at many New York drugstores.

A new software system, called CoagClinic, is helping hospitals manage their patients on anticoagulation therapy.

Sen. Henry Waxman holds a hearing on what can be done to curb hospital infections

Medtronic's recent recall of its implantable infusion systems underscores the need for health professionals to watch for inflammatory masses.

This special report takes a look at the atrial fibrillation drugs in the pipeline.

The AAN annual meeting in Chicago, researchers reported advances in treatments for a variety of neurological diseases

Patients who are taking opioids to relieve their severe pain and who are constipated can now use the new drug Relistor.

A final rule from CMS makes no requirements for a pharmacist to be part of the dialysis team, creating concern among hospital pharmacists.

New indications, formulations, drugs, generics and over the counter products

Three new initiatives are pushing electronic medical records like never before.

NACDS and NCPA respond to new CMS rules on e-prescribing.

FMI supermarket pharmacy conference attendees learn what new pharmacy services deparment's priorities are for 2008.

A compliance guidance for nursing homes proposed by the OIG emphasizes the need for appropriate pharmaceutical care.

The FDA recently held a hearing on behind the counter class of drugs. This article looks at the positions of various pharmacy associations and pharmacists.

Manufacturers are unleasing new over the counter insect repellents just in time for summer.

FDA approves new biologic to reduce symptoms of Crohn's disease